HIV-associated primary body-cavity-based lymphoma: Clinico-biologic features in three patients diagnosed at the same institution;Linfoma primario de cavidades asociado a infección por VIH: Características clínico-biológicas en tres pacientes diagnosticados en un mismo centro

Anales de Medicina Interna

Volumn 21, Issue 4, 2004, Pages 175-178

  Rodriguez Salazar M J ^a   Raya Sánchez, José María ^a,b   Rodriguez Sanchez R ^a   Alonso Socas, M M ^a   Brito Barroso, M L ^a   Hernandez Nieto L ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b NONE   (Spain)

Author keywords

HIV; Human immunodeficiency virus; Primary effusion lymphoma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KAPOSI SARCOMA; LYMPHOCYTE COUNT; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PRIMARY EFFUSION LYMPHOMA;

ADULT; BIOPSY; CD4 LYMPHOCYTE COUNT; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; PLEURA; PLEURAL CAVITY;

EID: 17944388305     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Dal Maso L, Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 2003; 4: 110-9.
2. Morassut S, Vaccher E, Balestreri L, Gloghini A, Gaidano G, Volpe R, et al. HIV-associated human herpesvirus 8-positive primary lymphomatous effusions: radiologic findings in six patients. Radiology 1997; 203: 459-63.
3. Banks PM, Warnke RA. Primary effusion lymphoma. En: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. Lyon, IARC Press; 2001, p. 179-80.
4. Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, et al. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med 1998; 339: 444-9.
5. Dotti G, Fiocchi R, Motta T, Facchinetti B, Chiodini B, Borleri GM, et al. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia 1999; 13: 664-70.
6. Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996; 88: 3124-8.
7. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MO, Sald J, et al. Primary effusion lymphoma: A distinct clinico-pathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645-56.
8. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
9. Karcher DS, Alkan S. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. Hum Pathol 1997; 28: 8018.
10. Cannon M, Philpott NJ, Cesarman E. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J Virol 2003; 77: 57-67.
11. Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, et al. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 1997; 90: 1186-91.
12. Komanduri KV, Luce JA, McGrath MS, Herndier BG, Ng VL. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 215-26.
13. Ansari MQ, Dawson DB, Nador R, Rutherford C, Schneider NR, Latimer MJ, et al. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996; 105: 221-9.
14. Ascoli V, Mastroianni CM, Galati V, Sirianni MC, Fruscalzo A, Pistilli A, et al. Primary effusion lymphoma containing human herpesvirus 8 DNA in two AIDS patients with Kaposi's sarcoma. Haematologica 1998; 83: 8-12.
15. Said JW, Shintaku IP, Asou H, de Vos S, Baker J, Hanson G, et al. Herpesvirus 8 inclusions in primary effusion lymphomas: report of a unique case with T-cell phenotype. Arch Pathol Lab Med 1999; 123: 257-60.
16. Gaidano G, Gloghini A, Gattei V, Rossi MF, Cilia AM, Godeas C, et al. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood 1997; 90: 4894-900.
17. Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 2000; 96: 2537-42.
18. Asou H, Said JW, Yang R, Munker R, Park DJ, Kamada N, et al. Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 1998; 91: 2475-81.
19. Ghosh SK, Wood C, Boise LH, Mian AM, Deyev VV, Feuer G, et al. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappaB. Blood 2003; 2321-7.